RadPharm raises $10M, led by Siemens Venture Capital
Dec. 5 – RadPharm, a provider of medical image review services for clinical research, has completed a $10 million Series B financing led by Siemens Venture Capital.
The Princeton, N.J.-based Radpharm said its existing investors, Ampersand Ventures, Adams Street Partners and Tang Capital Management, participated in the financing.
Ronald A. Berg, president and CEO of RadPharm, said that the company will use the financing of more than 60 sponsors to support its review services for more than 250 clinical trials and the opening of an office in Munich, Germany.
The Princeton, N.J.-based Radpharm said its existing investors, Ampersand Ventures, Adams Street Partners and Tang Capital Management, participated in the financing.
Ronald A. Berg, president and CEO of RadPharm, said that the company will use the financing of more than 60 sponsors to support its review services for more than 250 clinical trials and the opening of an office in Munich, Germany.